Copyright
©The Author(s) 2015.
World J Stem Cells. Mar 26, 2015; 7(2): 243-252
Published online Mar 26, 2015. doi: 10.4252/wjsc.v7.i2.243
Published online Mar 26, 2015. doi: 10.4252/wjsc.v7.i2.243
Substrate | Advantages | Disadvantages |
Matrigel | Allows feeder-free cell culture | Xenogeneic origin[6] |
Inexpensive | Undefined components[6] | |
Long-term hESCs culture[7,8] | Pathogenic contamination risk[4] | |
Neu5Gc immunogenic epitope[5] | ||
Batch-to-batch variability[6] | ||
ECM proteins | See subsections below | Batch-to-batch variability |
Vitronectin | Degradation upon sterilization | |
rhLM-332 | Pathogenic contamination risk | |
LM-E8 | Not-Scalable[30] | |
rh E-cadherins-Fc protein | High production cost[30] | |
Fibronectin | Immunogenicity risk[17] | |
Vitronectin | Long-term hESC culture (> 30 passages)[15] | Degradation upon sterilization |
αVβ5 integrin receptor mediated cell attachment[13] | Not-Scalable[16,30] | |
High production cost[30] | ||
rhLM-332 | High α6β1 integrin affinity[18] | |
LM-E8 | Smaller, easily purified, higher purity vs 780 ku laminins[20] | Not-Scalable[30] |
Better stem cell adhesion than Matrigel and intact laminins[20] | High production cost[30] | |
ROCK inhibitor Y-27632 not needed[20] | ||
rh E-cadherins-Fc protein | hESC self-renewal, maintenance and pluripotency comparable to Matrigel™[26] | Low cell adherence vs Matrigel[26] |
Synthetic peptides | No batch-to-batch variation[36] | High production costs[47,48] |
Immunogenicity risk avoided[37] | Sterilization difficulties[47] | |
Since chemically synthesized | Easily degradable[47] | |
Long-term hESCs culture[32,37,44] | Labor intensive cell passaging | |
Limited scale-up potential of 2D platform[51] | ||
Synthemax surface | Gamma irradiation sterilization[39] | |
2 yr shelf-life[39] | ||
hESCs cryopreserved and thawed on substrate[38] | ||
Scalable[38] | ||
Long-term hESCs culture[38-40] | ||
Synthetic polymers | Inexpensive[45,47] | Limited scale-up potential of 2D platform |
PMVE-alt-MA | Easy and rapid fabrication[45,49] | |
PMEDSAH | Highly manipulable[47] | |
APMAAm | Long-term substrate stability[46] | |
Polyacrylates | ||
Chitosan-alginate polymers | ||
(pDTEc) polymer scaffolds | ||
Hydrogels | In-vivo 3D type environment[58] | Difficult to analyze cells embedded in hydrogels |
Thermoresponsive and pH sensitive properties[54,55,58] | ||
(AEtMA-Cl)- DEAEA based | Enzymatic release of cells from hydrogel[57] | |
PDEAAm-based | ||
HA-based | ||
Alginate-collagen based | ||
PEG-based | ||
PPP-based |
- Citation: Enam S, Jin S. Substrates for clinical applicability of stem cells. World J Stem Cells 2015; 7(2): 243-252
- URL: https://www.wjgnet.com/1948-0210/full/v7/i2/243.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v7.i2.243